查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1559906

经导管主动脉瓣置换术(TAVR) 市场报告：2030 年趋势、预测与竞争分析

Transcatheter Aortic Valve Replacement (TAVR) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

经导管主动脉瓣置换术(TAVR) 趋势与预测

预计到 2030 年，全球经导管主动脉瓣置换术(TAVR) 市场将达到 198 亿美元，2024 年至 2030 年复合年增长率为 16.5%。该市场的主要驱动因素是主动脉瓣狭窄病例数量的增加、瓣膜置换术微创手术需求的增加以及 TAVR 设备的持续技术进步。全球经导管主动脉瓣置换术（TAVR）市场未来性广阔，医院市场和门诊手术中心市场机会庞大。

  • Lucintel 预测，无缝线瓣膜将在预测期内实现高速成长。
  • 预计北美地区在预测期内将出现最高的成长。

经导管主动脉瓣置换术(TAVR) 市场的新兴趋势

TAVR 市场的新兴趋势正在刺激创新方法的发展，以扩大微创心臟瓣膜手术。这反映了不断进步的技术发展、不断发展的临床实践和不断变化的患者需求。

  • 改良的阀门设计：新一代 TAVR 阀门采用改良的设计，可提高耐用性、减少旁瓣洩漏并优化性能。这些增强功能可以改善患者的治疗效果，并将 TAVR 的适用性扩展到更复杂的病例。
  • 微创技术：微创手术正在兴起，新的输送系统和方法不断发展。这种手术降低了手术风险和恢復时间，并将 TAVR 的使用范围扩大到了更多的患者群体。
  • 低风险患者：TAVR 越来越不仅适用于高风险患者，也适用于低风险患者。临床研究报告了更多患者的良好治疗结果，刺激了 TAVR 手术的增加。
  • 先进的影像整合：先进的影像技术整合到手术中，例如 3D 超音波心动图和 CT 成像，进一步完善了 TAVR 手术。增强的诊断影像可以更好地规划和调整瓣膜尺寸，从而实现更准确的放置和更好的治疗结果。
  • 新兴市场的成长：由于医疗基础设施和意识的改善，TAVR 市场在新兴市场正在成长。中国、印度等新兴国家正迅速采用TAVR技术。这可能是由于这些国家患者的需求不断增加，并且容易获得先进的医疗设备。

新兴趋势包括改进的瓣膜设计、微创技术、扩展到低风险患者、先进影像诊断的整合以及新兴市场的成长，所有这些都在塑造 TAVR 格局。这些变化正在透过推动创新、改善成果和扩大全球适应范围来重塑该领域。

经导管主动脉瓣置换术(TAVR) 市场的最新趋势

近年来，TAVR 市场在技术、监管核准和临床考虑方面出现了显着趋势。这些因素共同提高了 TAVR 手术的有效性、安全性和可近性。

  • 阀门技术的进步：新设计的阀门采用先进材料和卓越的机械特性製造，可减少併发症并提高耐用性。这改善了长期结果并提高了患者满意度。
  • 新设备核准：最近监管部门核准了新 TAVR 设备，扩大了治疗选择。持续的发展包括使用更薄的瓣膜和改进的输送系统，进一步扩大 TAVR 手术的适应症，以包括更复杂的解剖候选者。
  • 扩大适应症：TAVR 的适应症正在扩大，包括低风险患者和具有独特解剖特征的患者，临床证据表明这些新群体的结果良好，证据正在累积。
  • 改善临床结果：使用最新 TAVR 技术的临床研究表明，临床结果得到改善，包括更低的併发症发生率和更高的手术成功率。这些改进提高了 TAVR 作为治疗选择的采用率和信心。
  • 全球采用率不断提高：TAVR 正逐渐在全球范围内获得关注，新兴市场和其他先前访问受限的地区的采用率不断增加。这项进展得益于技术的改进和为改善 TAVR 治疗机会所做的努力。

TAVR 的最新进展包括瓣膜技术的进步、监管部门的核准、适应症的扩大、临床结果的改善以及全球接受度的扩大，所有这些都致力于改善治疗前景。这些发展有助于 TAVR 手术在全球范围内的日益接受和成功。

经导管主动脉瓣置换术(TAVR) 市场的策略性成长机会

TAVR 市场在应用和地区持续出现策略性成长机会。这些都是由不断的技术进步、临床进步以及患者对心臟瓣膜微创治疗的需求增加所推动的。

  • 新兴市场渗透率：随着医疗保健基础设施的发展，新兴市场具有很高的成长潜力。新兴市场中 TAVR 的日益普及将为解决未满足的需求和市场渗透提供新的机会。
  • 开发下一代设备：投资具有改进功能和性能的下一代 TAVR 设备将为进一步成长铺平道路。低轮廓阀门和先进输送系统的持续开发将继续改善采用率和患者治疗效果。
  • 与数位健康解决方案整合：将 TAVR 手术与远端监控和资料分析等数位健康解决方案相结合，可增强患者管​​理和手术规划。这不仅改善了临床结果，而且使业务更有效率。
  • 扩大 TAVR 的适应症：将 TAVR 的适应症扩大到低风险患者和不同的解剖病例也带来了成长机会。这些新患者群体的积极成果可以扩大市场并提高采用率。
  • 伙伴关係与联盟：设备製造商、医疗保健提供者和研究机构之间的策略伙伴关係和合作可以加速创新并扩大市场范围。这些合作伙伴关係预计将加快产品开发并加强临床实践。

TAVR市场策略性成长的成长机会包括拓展新兴市场、开发下一代设备、融入数位健康解决方案、扩大适应症和策略联盟。这些可能会刺激市场进一步成长，并进一步促进 TAVR 手术的便利性和高效性。

经导管主动脉瓣置换术(TAVR) 市场驱动因素与挑战

TAVR 市场受到各种驱动因素​​和挑战的主导。主要市场驱动因素包括技术进步、监管因素、经济考量和不断发展的临床实践。识别这些因素对于成功驾驭这个市场并最终实现成长非常重要。

推动经导管主动脉瓣置换术（TAVR）市场的因素包括：

1. 创新：瓣膜设计和输送系统的创新使 TAVR 成为一个不断进步的领域。新设备可确保性能并减少併发症，从而改善患者的治疗效果。这些被认为是提高采用率并进而带来市场成长的关键点。

2.扩大适应症：扩大TAVR的适应症，包括低风险患者和更复杂的解剖结构，是推动市场需求的关键驱动因素之一。这些新病患小组的积极临床结果正在扩大市场和对该手术的接受度。

3. 微创手术的需求不断增长：微创手术的日益普及正在推动对 TAVR 的需求。由于 TAVR 术后的恢復时间比传统的心臟直视手术短，因此患者和医疗保健提供者认为 TAVR 是更好的选择，因为手术风险较低。

4. 监管机构核准：TAVR 设备的新核准和扩大的适应症正在推动市场发展。主要医疗机构的核准增加了先进技术的可用性，并增强了对其使用的信心。

5. 改善医疗基础设施：医疗基础设施的开拓正在改善先进技术的获取，并推动 TAVR 市场的成长，特别是在新兴市场。

经导管主动脉瓣置换术(TAVR) 市场面临的挑战包括：

1. 手术成本高：手术和设备的高成本阻碍了广泛采用，特别是在资源匮乏的环境中。为了克服成本挑战并增加价值，展示更好的治疗效果对于市场扩张至关重要。

2. 监管挑战：必须满足非常复杂的监管要求才能获得新器械和适应症的核准。市场进入和创新的驱动力是监管延迟和严格要求。

3.报销政策有限：大多数地区对TAVR治疗的报销政策有限，限制了取得和采用。广泛的市场接受需要扩大报销范围并展示成本效益。

TAVR 的成长将受到技术创新、适应症扩大、对最少介入程序的需求、监管核准和改善的医疗基础设施的推动。然而，这些都被高昂的手术费用、监管过程中的挑战以及令人不满意的报销政策所抵消。因此，解决这些挑战是持续成长和广泛采用的途径。

按细分市场分類的经导管主动脉瓣置换术(TAVR) 的趋势

本研究按产品类型、材料、最终用途和地区对全球经导管主动脉瓣置换术(TAVR) 进行预测。

经导管主动脉瓣置换术(TAVR) 市场国家展望

经导管主动脉瓣置换术市场涉及广泛的技术进步，设备技术的巨大开拓、采用率的不断提高以及对微创手术的需求不断增长正在引起人们的兴趣。技术创新透过扩大适应症和简化程序来改善患者的治疗结果。美国、中国、德国、印度、日本等世界主要地区在TAVR技术和应用的发展上呈现出全球动能。

  • 美国：在美国，由于瓣膜设计和手术的进步，TAVR 市场正在快速成长。主要进展包括 FDA核准使用新一代瓣膜，该瓣膜拥有更好的输送系统和低调的设计，以更低的手术风险扩大了患者群体。
  • 中国：由于意识的提高和医疗基础设施的改善，TAVR 市场正在经历快速成长。最新进展：随着微创心臟瓣膜置换术需求的增长，本地开发的 TAVR 设备已获得中国医院的核准和采用。
  • 德国：例如德国已经全面采用了目前先进的TAVR技术。最近的改进包括提高设备性能和改善患者相关结果，瓣膜设计和输送系统的改进可改善临床结果并减少手术併发症。在印度，其在年轻患者和具有复杂解剖结构的患者中的使用也在扩大。
  • 印度：随着性能更高的设备和越来越多的人获得更好的医疗保健，印度的 TAVR 市场正在不断改善。最近的进展包括过去几年与国际公司建立的多项开发合作伙伴关係，以推出新版本的 TAVR 技术并扩大该地区严重主动脉瓣狭窄患者的治疗选择。
  • 日本：由于新兴技术和支持经导管主动脉瓣置换术置换术也出现成长。这包括广泛使用日本製造的 TAVR 设备以及扩大临床试验以评估区域患者群体的长期治疗结果和疗效。

常问问题

Q.1 经导管主动脉瓣置换术（TAVR）的市场规模有多大？

A1. 到 2030 年，全球经导管主动脉瓣置换术(TAVR) 市场预计将达到 198 亿美元。

Q.2 经导管主动脉瓣置换术(TAVR) 市场的成长预测是多少？

A2. 2024年至2030年，全球经导管主动脉瓣置换术（TAVR）市场预计将以16.5%的复合年增长率成长。

Q.3 影响经导管主动脉瓣置换术(TAVR) 市场成长的关键驱动因素有哪些？

A3. 该市场的主要驱动力是主动脉瓣狭窄病例数量的增加、瓣膜置换术微创手术的需求增加以及 TAVR 设备的持续技术进步。

Q4.市场的主要细分市场是：

A4. 经导管主动脉瓣置换术（TAVR）市场未来性广阔，医院市场和门诊手术中心市场充满机会。

Q5.市场的主要企业是：

A5. 经导管主动脉瓣置换术（TAVR）的主要企业是：

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，无缝线瓣膜将在预测期内实现高速成长。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 预计北美地区在预测期内将出现最高成长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球经导管主动脉瓣置换术（TAVR）市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球经导管主动脉瓣置换术（TAVR）市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球经导管主动脉瓣置换术(TAVR) 市场
    • 经导管主动脉瓣
    • 无缝线瓣膜
    • 其他的
  • 全球经导管主动脉瓣置换术（TAVR）市场（按材质）
    • 不銹钢
    • 镍钛诺
    • 钴铬合金
    • 其他的
  • 以最终用途分類的经导管主动脉瓣置换术(TAVR) 的全球市场
    • 医院
    • 门诊手术中心
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球经导管主动脉瓣置换术（TAVR）市场（按地区）
  • 北美经导管主动脉瓣置换术术 (TAVR) 市场
  • 欧洲经导管主动脉瓣置换术（TAVR）市场
  • 亚太地区置换术(TAVR) 市场
  • 其他地区经导管主动脉瓣置换术（TAVR）市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球经导管主动脉瓣置换术(TAVR) 市场成长机会
    • 全球经导管主动脉瓣置换术(TAVR) 市场按材质的成长机会
    • 全球经导管主动脉瓣置换术(TAVR) 市场成长机会（依最终用途）
    • 全球经导管主动脉瓣置换术(TAVR) 市场成长机会（按地区）
  • 全球经导管主动脉瓣置换术(TAVR) 市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球经导管主动脉瓣置换术(TAVR) 市场容量扩张
    • 全球经导管主动脉瓣置换术(TAVR) 市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences
简介目录

Transcatheter Aortic Valve Replacement (TAVR) Trends and Forecast

The future of the global transcatheter aortic valve replacement (TAVR) market looks promising with opportunities in the hospital and ambulatory surgical centre markets. The global transcatheter aortic valve replacement (TAVR) market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 16.5% from 2024 to 2030. The major drivers for this market are rising cases of aortic stenosis, growing demand for minimally invasive procedures for valve replacement, and continuous technological advancements in TAVR devices.

  • Lucintel forecasts that sutureless valve is expected to witness higher growth over the forecast period.
  • North America is expected to witness highest growth over the forecast period.

Emerging Trends in the Transcatheter Aortic Valve Replacement (TAVR) Market

The emerging trends in the TAVR market stimulate innovative approaches toward broadening minimally invasive heart valve procedures. This reflects progressive technology development, evolving clinical practices, and changing patient needs.

  • Improved Valve Designs: New-generation TAVR valves boast of their improved design for better durability, reduced paravalvular leakage, and performance optimization. These enhancements translate to improvements in patient outcomes and extend the applicability of TAVR to more complex cases.
  • Minimally Invasive Techniques: Less-invasive techniques continue to be on the rise, while new delivery systems and approaches continue to be developed. Such techniques reduce procedural risks and recovery times, extending the use of TAVR to a larger patient population.
  • Lower-Risk Patients: TAVR is being indicated for not only high-risk patients but increasingly for those with lower risk, as well. Clinical studies are reporting positive outcomes for the expanded patient group, fueling growth of TAVR procedures.
  • Advanced Imaging Integration: Advanced imaging technologies integrated into the procedure-such as 3D echocardiography and CT imaging-are further refining the art of performing a TAVR. Enhanced imaging aids in yielding better planning and valve sizing, providing greater placement accuracy, and fostering even better procedural outcomes.
  • Growth in Emerging Markets: The TAVR market is growing in emerging markets because of increasing health infrastructures and awareness. In developing countries like China and India, TAVR technology is being adopted very fast. This may be attributed to the ever-rising demand by the patients in these countries and accessibility to medical devices that are advanced.

The emerging trends include improved valve designs, minimally invasive techniques, expansion to lower-risk patients, integration of advanced imaging, and rising growth in emerging markets-all contribute to remodeling the landscape of TAVR. These changes have reshaped this space by driving innovation, improving outcomes, and expanding its indications around the world.

Recent Developments in the Transcatheter Aortic Valve Replacement (TAVR) Market

There are vast developments in technology, regulatory approvals, and clinically related matters in the TAVR market over the recent years. These factors have combined to improve the efficacy, safety, and access of procedures using TAVR.

  • Advances in Valve Technology: Newer designs of valves are being manufactured with advanced materials and better mechanical features that reduce complications and enhance durability. This leads to improved long-term results and increased satisfaction for patients.
  • Regulatory Approval for New Devices: Recent regulatory approvals of newer TAVR devices have expanded treatment options. Ongoing developments include the availability of smaller-profile valves and improved delivery systems that will further expand the candidacy for the TAVR procedure to include more complex anatomic candidates.
  • Indications Expansion: TAVR indications are increasingly being given for patients with low risk and those exhibiting unique anatomical features, with the accumulation of supportive clinical evidence demonstrating favorable outcomes across these newer cohorts.
  • Improved Clinical Outcomes: Clinical studies are demonstrating improved clinical outcomes using the latest TAVR technologies, with lower complication rates and better procedural success. Such improvements are driving up adoptions and confidence in TAVR as a therapeutic option.
  • Increasing Global Adoption: TAVR is gradually gaining momentum globally, with deeper penetration in emerging markets and other geographies where access was earlier limited. This development is thus supported by the technology improvements and efforts being done to increase access to TAVR procedures.

Recent advances in TAVR comprise progress on the fronts of valve technology, regulatory approvals, indication expansion, improvement in clinical outcomes, and greater global acceptance, all acting to improve the landscape for treatment. Such developments are contributing to increased acceptance and success of the TAVR procedures globally.

Strategic Growth Opportunities for Transcatheter Aortic Valve Replacement (TAVR) Market

Growth opportunities in strategic positions continue to emerge in the TAVR market for applications and regions. These are driven by continuous technological advancements, evolving clinical practices, and increasing patient demand for minimally invasive treatments of the heart valves.

  • Emerging Market Penetration: Emerging markets represent a high growth potential as healthcare infrastructure develops. Emerging markets should witness increased availability of TAVR and offer new opportunities for addressing unmet needs and greater market penetration.
  • Development of Next-Generation Devices: Investment in next-generation TAVR devices with enhanced feature and performance capabilities creates further avenues for growth. Ongoing development of smaller profile valves and advanced delivery systems continues to improve adoption and patient outcomes.
  • Integration with Digital Health Solutions: Combining TAVR procedures with digital health solutions-such as remote monitoring and data analytics-will enhance patient management and procedural planning. This allows for not only better clinical outcomes but also operational efficiencies.
  • Expanding Indications for TAVR: Further indications of TAVR into lower-risk patients and a range of anatomical cases also open up opportunities for growth. Positive outcomes from such new patient groups can expand the market and increase adoption.
  • Partnerships and Collaborations: Strategic partnerships and collaborations between device manufacturers, healthcare providers, and research institutions can accelerate innovation and extend the reach of the market. These partnerships may speed up product development and enhance clinical practices.

Growth opportunities in the strategic growth of the TAVR market include expansion into emerging markets, next-generation device development, integration into digital health solutions, expansion of indications, and strategic partnerships. These will probably spur further growth of the market and further facilitate easier access to and higher efficacy of TAVR procedures.

Transcatheter Aortic Valve Replacement (TAVR) Market Driver and Challenges

The TAVR market is governed by various drivers and challenges. Some of the key drivers in the market would include technological advances, regulatory factors, economic considerations, and evolving clinical practices. Discerning these factors becomes important in order to maneuver in this market and eventually achieve growth.

The factors responsible for driving the transcatheter aortic valve replacement (tavr) market include:

1. Innovations in Technology: Technological innovations in valve design and delivery systems are what make TAVR an advancing field. New devices ensure that there is a performance with fewer complications; therefore, better patient outcomes are realized. These are considered points for increasing the adoption rate and, hence, the growth of the market.

2. Expanding Indications: Indication expansion of TAVR to include lower-risk patients and more complex anatomies is one of the major propellers driving market demand. Positive clinical outcomes from these newer patient groups are expanding the market and acceptance of this procedure.

3. Growing Demand for Minimally Invasive Procedures: Growing adoption of minimally invasive procedures fuels the demand for TAVR. Recovery time after TAVR is less compared to conventional open-heart surgery, and hence patients and health providers consider TAVR a better option due to less procedural risk.

4. Regulatory Approvals: New TAVR device approvals and expanded indications are propelling the market. Major health authority approvals improve advanced technology availability and instill confidence in the use of that technology.

5. Healthcare Infrastructure Improvements: The development of healthcare infrastructure is allowing for improved accessibility of advanced technologies and hence promoting the market growth for TAVR, especially in the developing markets.

Challenges in the transcatheter aortic valve replacement (tavr) market are:

1. High Cost of the Procedure: The high cost of the procedure and devices prohibits wide adoption, particularly in resource-poor settings. To overcome the cost-related challenges and value, showing better outcomes are essential for market expansion.

2. Regulatory Challenges: We have to course through very complex regulatory requirements and obtain approvals of both new devices and indications. The drivers of market entry and innovation are regulatory delays and stringent requirements.

3. Limited Reimbursement Policies: In most regions, the limited reimbursement policy for TAVR procedures will provide limited access and adoption. Expanding reimbursement coverage and demonstrating cost-effectiveness are required for wider market acceptance.

The growth of TAVR is propelled by technology innovations, expanding indications, demand for minimal access procedures, regulatory approvals, and improving infrastructure in healthcare. These, in turn, are offset by high procedure costs, woes in the regulatory process, and unsatisfactory reimbursement policies. Thereby, resolving these challenges is the way to continued growth and wider adoption.

List of Transcatheter Aortic Valve Replacement (TAVR) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies transcatheter aortic valve replacement (TAVR) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transcatheter aortic valve replacement (TAVR) companies profiled in this report include-

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Transcatheter Aortic Valve Replacement (TAVR) by Segment

The study includes a forecast for the global transcatheter aortic valve replacement (TAVR) by product type, material, end use, and region.

Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type [Analysis by Value from 2018 to 2030]:

  • Transcatheter Aortic Valve
  • Sutureless Valve
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by Material [Analysis by Value from 2018 to 2030]:

  • Stainless Steel
  • Nitinol
  • Cobalt Chromium
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by End Use [Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

Transcatheter Aortic Valve Replacement (TAVR) Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Transcatheter Aortic Valve Replacement (TAVR) Market

The transcatheter aortic valve replacement market has been a wide technology advancement area in which huge development of device technology, increasing adoption, and growing demand for minimally invasive procedures are driving interest. Innovations improve patient outcomes by expanding indications and improving procedural efficiencies. Various key regions of the world, including the United States, China, Germany, India, and Japan, show global momentum in the development of TAVR technology and applications.

  • United States: In the United States, the TAVR market is rapidly growing due to the advancement in valve designs and procedural techniques. Key developments include the FDA's approvals for the use of newer-generation valves boasting better delivery systems and lower-profile designs to expand the patient population with low surgical risk.
  • China: The increasing awareness and improvement in healthcare infrastructure mean that, very fast growth is seen in the TAVR market. Recent Developments: Locally developed TAVR devices in China reach approval and get adopted by the hospitals amidst the expanding demand for minimally invasive heart valve replacements.
  • Germany: For instance, Germany has fully embraced the current advanced TAVR technology. Recent improvements include enhancing device performance and better patient-related outcomes, with specific refinements in valve design and better delivery systems, translating to better clinical outcomes and reduced procedural complications. The country is also expanding its use in younger patients and those with complex anatomy.
  • India: The TAVR market of India is improving, with growing access to higher devices and better healthcare. Several of the recent development partnerships are with international companies during the last years for the newer versions' introduction of TAVR technologies and expansion of treatment options for patients with severe aortic stenosis in regions.
  • Japan: Japan is also showing growth in the Transcatheter aortic valve replacement market with emerging technologies and supportive clinical evidence for the indication of Transcatheter aortic valve replacement in wider groups of patients. This includes the penetration of Japanese handmade TAVR devices along with expansion of clinical trials for estimating long term and efficacy outcome in local patient sets.

Features of the Global Transcatheter Aortic Valve Replacement (TAVR) Market

Market Size Estimates: Transcatheter aortic valve replacement (TAVR) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Transcatheter aortic valve replacement (TAVR) market size by product type, material, end use, and region in terms of value ($B).

Regional Analysis: Transcatheter aortic valve replacement (TAVR) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, materials, end uses, and regions for the transcatheter aortic valve replacement (TAVR) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transcatheter aortic valve replacement (TAVR) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What is the transcatheter aortic valve replacement (TAVR) market size?

Answer: The global transcatheter aortic valve replacement (TAVR) market is expected to reach an estimated $19.8 billion by 2030.

Q.2 What is the growth forecast for transcatheter aortic valve replacement (TAVR) market?

Answer: The global transcatheter aortic valve replacement (TAVR) market is expected to grow with a CAGR of 16.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the transcatheter aortic valve replacement (TAVR) market?

Answer: The major drivers for this market are rising cases of aortic stenosis, growing demand for minimally invasive procedures for valve replacement, and continuous technological advancements in TAVR devices.

Q4. What are the major segments for transcatheter aortic valve replacement (TAVR) market?

Answer: The future of the transcatheter aortic valve replacement (TAVR) market looks promising with opportunities in the hospital and ambulatory surgical centre markets.

Q5. Who are the key transcatheter aortic valve replacement (TAVR) market companies?

Answer: Some of the key transcatheter aortic valve replacement (TAVR) companies are as follows:

  • CryoLife
  • Abbott
  • Micro Interventional Devices
  • Boston Scientific
  • LivaNova
  • Meril Life Sciences
  • Edwards Lifesciences

Q6. Which transcatheter aortic valve replacement (TAVR) market segment will be the largest in future?

Answer: Lucintel forecasts that sutureless valve is expected to witness higher growth over the forecast period.

Q7. In transcatheter aortic valve replacement (TAVR) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the transcatheter aortic valve replacement (TAVR) market by product type (transcatheter aortic valve, sutureless valve, and others), material (stainless steel, nitinol, cobalt chromium, and others), end use (hospitals, ambulatory surgical centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
  • Market Report

Table of Contents

1. Executive Summary

2. Global Transcatheter Aortic Valve Replacement (TAVR) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type
    • 3.3.1: Transcatheter Aortic Valve
    • 3.3.2: Sutureless Valve
    • 3.3.3: Others
  • 3.4: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Material
    • 3.4.1: Stainless Steel
    • 3.4.2: Nitinol
    • 3.4.3: Cobalt Chromium
    • 3.4.4: Others
  • 3.5: Global Transcatheter Aortic Valve Replacement (TAVR) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Ambulatory Surgical Centres
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region
  • 4.2: North American Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.2.1: North American Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.2.2: North American Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.3: European Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.3.1: European Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.3.2: European Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.4: APAC Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.4.1: APAC Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.4.2: APAC Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others
  • 4.5: ROW Transcatheter Aortic Valve Replacement (TAVR) Market
    • 4.5.1: ROW Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type: Transcatheter Aortic Valve, Sutureless Valve, and Others
    • 4.5.2: ROW Transcatheter Aortic Valve Replacement (TAVR) Market by End Use: Hospitals, Ambulatory Surgical Centres, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Material
    • 6.1.3: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Transcatheter Aortic Valve Replacement (TAVR) Market by Region
  • 6.2: Emerging Trends in the Global Transcatheter Aortic Valve Replacement (TAVR) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Transcatheter Aortic Valve Replacement (TAVR) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transcatheter Aortic Valve Replacement (TAVR) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: CryoLife
  • 7.2: Abbott
  • 7.3: Micro Interventional Devices
  • 7.4: Boston Scientific
  • 7.5: LivaNova
  • 7.6: Meril Life Sciences
  • 7.7: Edwards Lifesciences